Person

Sophie Vandebroek V

Director, Idexx Laboratories

Current S&P 500 boards
2
Current roles
2
Open-market buys
$0
Open-market sales
$10.5M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Feb 17, 2026IDXXSale945$628.65$594K
Feb 17, 2026IDXXSale519$628.56$326K
May 9, 2025IDXXSale1,279$491.34$628K
Nov 27, 2024IDXXSale344$420.44$145K
Mar 5, 2024IDXXSale1,404$562.98$790K
May 4, 2023IDXXSale2,187$469.02$1.0M
Feb 12, 2021IDXXSale3,046$538.20$1.6M
Feb 18, 2020IDXXSale5,902$286.89$1.7M
Feb 18, 2020IDXXSale1,666$286.89$478K
Aug 5, 2019IDXXSale6,056$263.86$1.6M
Aug 5, 2019IDXXSale2,988$263.86$788K
Aug 3, 2018IDXXSale1,750$240.64$421K
Aug 3, 2018IDXXSale1,515$240.64$365K

SEC reporting-owner ID (CIK) 1442078 · all filings on EDGAR

Sophie Vandebroek V (IDXX, RVTY) | USBoard